Chemoinformaics analysis of 17-Pentatriacontene
| Molecular Weight | 490.945 | nRot | 31 |
| Heavy Atom Molecular Weight | 420.385 | nRig | 6 |
| Exact Molecular Weight | 490.548 | nRing | 0 |
| Solubility: LogS | -0.011 | nHRing | 0 |
| Solubility: LogP | 1.733 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 105 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 70 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 105.126 |
| nHD | 0 | BPOL | 70.2245 |
| QED | 0.617 |
| Synth | 2.494 |
| Natural Product Likeliness | -0.877 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.005 |
| HIA | 0.004 |
| CACO-2 | -4.487 |
| MDCK | 0.0000307 |
| BBB | 0.816 |
| PPB | 0.388985 |
| VDSS | 1.671 |
| FU | 0.55464 |
| CYP1A2-inh | 0.9 |
| CYP1A2-sub | 0.776 |
| CYP2c19-inh | 0.132 |
| CYP2c19-sub | 0.578 |
| CYP2c9-inh | 0.074 |
| CYP2c9-sub | 0.279 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.343 |
| CYP3a4-inh | 0.213 |
| CYP3a4-sub | 0.432 |
| CL | 10.795 |
| T12 | 0.731 |
| hERG | 0.031 |
| Ames | 0.004 |
| ROA | 0.223 |
| SkinSen | 0.913 |
| Carcinogencity | 0.17 |
| EI | 0.74 |
| Respiratory | 0.799 |
| NR-Aromatase | 0.036 |
| Antiviral | No |
| Prediction | 0.575843 |